Aristeidis Fasoulas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aristeidis Fasoulas has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Constantinos Giaginis
Department of Food Science and Nutrition, University of the Aegean, 81400 Lemnos, Greece
5 shared publications - Eleni Pavlidou
Department of Nutritional Sciences and Dietetics, School of Health Sciences, International Hellenic University, 57400 Thessaloniki, Greece
5 shared publications - Sousana Konstantinos Papadopoulou
Department of Nutritional Sciences and Dietetics, International Hellenic University, 57001 Thessaloniki, Greece
5 shared publications - Eleni Melenikioti
Department of Nutritional Sciences and Dietetics, School of Health Sciences, International Hellenic University, 57400 Thessaloniki, Greece
2 shared publications - Antonios Dakanalis
School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy
1 shared publication - Efthymios Poulios
Department of Food Science and Nutrition, University of the Aegean, 81400 Lemnos, Greece
1 shared publication
Latest Publications
- Open Access
- 21 October 2026
- Published by MDPI AG in Diabetology
- Vol. 7 (10) , 208
Beyond Hydration: Natural Mineral Water and Metabolic Health
Background: Natural mineral water (NMW) is a heterogeneous dietary exposure whose composition varies substantially among sources. Objective: This critical review examines human intervention evidence on NMW in relation to metabolic health across healthy adults and populations with hypercholesterolaemia, type 2 diabetes mellitus (T2DM), and metabolic dysfunction-associated steatotic liver disease (MASLD) while separating direct clinical findings from mechanistic evidence. Methods: Seven principal human intervention studies were identified in the clinical synthesis. Results: Controlled studies did not show a reproducible glucose-lowering effect attributable to mineralwater composition. Selected studies nevertheless reported changes in postprandial insulin dynamics, glycoalbumin, oxidative status, gastrointestinal or microbiota-related variables, and intestinal, inflammatory, and hepatic outcomes. Calcium and magnesium in mineral water are bioavailable, but mineral absorption should not be interpreted as evidence of disease-specific efficacy. The literature is constrained by small samples, chemically dissimilar waters, heterogeneous populations, variable intervention durations, and inconsistent comparator designs. Conclusions: Accordingly, current evidence supports NMW primarily as a source-specific nutritional exposure rather than an established metabolic intervention. Future trials should use analytically characterized intervention and control waters, predefined outcomes, adequate durations, and clearly defined metabolic phenotypes to determine whether particular hydrochemical profiles produce reproducible metabolic effects.
- 21 October 2026
- Published by MDPI AG in Diabetology
- Vol. 7 (10) , 208
Open AccessBeyond Hydration: Natural Mineral Water and Metabolic Health
Background: Natural mineral water (NMW) is a heterogeneous dietary exposure whose composition varies substantially among sources. Objective: This critical review examines human intervention evidence on NMW in relation to metabolic health across healthy adults and populations with hypercholesterolaemia, type 2 diabetes mellitus (T2DM), and metabolic dysfunction-associated steatotic liver disease (MASLD) while separating direct clinical findings from mechanistic evidence. Methods: Seven principal human intervention studies were identified in the clinical synthesis. Results: Controlled studies did not show a reproducible glucose-lowering effect attributable to mineralwater composition. Selected studies nevertheless reported changes in postprandial insulin dynamics, glycoalbumin, oxidative status, gastrointestinal or microbiota-related variables, and intestinal, inflammatory, and hepatic outcomes. Calcium and magnesium in mineral water are bioavailable, but mineral absorption should not be interpreted as evidence of disease-specific efficacy. The literature is constrained by small samples, chemically dissimilar waters, heterogeneous populations, variable intervention durations, and inconsistent comparator designs. Conclusions: Accordingly, current evidence supports NMW primarily as a source-specific nutritional exposure rather than an established metabolic intervention. Future trials should use analytically characterized intervention and control waters, predefined outcomes, adequate durations, and clearly defined metabolic phenotypes to determine whether particular hydrochemical profiles produce reproducible metabolic effects.
- Open Access
- 18 August 2026
- Published by MDPI AG in Preprints.org
Natural Mineral Water and Metabolic Regulation in Type 2 Diabetes: Current Evidence, Mechanistic Insights, and Future Directions
Natural mineral water (NMW) represents a heterogeneous hydrochemical exposure whose metabolic effects may depend on its complete mineral and physicochemical profile. This critical review evaluates human evidence on NMW consumption in relation to glucose regulation and metabolic pathways relevant to type 2 diabetes mellitus (T2DM), while distinguishing clinical findings from mechanistic plausibility. Controlled studies have not demonstrated a consistent glucose-lowering effect: oral glucose tolerance and postprandial glucose responses were generally unchanged, while longer-term reductions in fasting glucose were not clearly attributable to water composition. Conversely, selected studies identified potentially relevant intermediate responses, including altered postprandial insulin dynamics, reduced glycoalbumin, changes in oxidative status, gastrointestinal and microbiota-related variables, and favourable intestinal, inflammatory, and liver-related outcomes in metabolic dysfunction-associated steatotic liver disease. Human studies also establish mineral water as a bioavailable source of magnesium and calcium, although bioavailability does not imply metabolic efficacy. Interpretation remains limited by small samples, heterogeneous hydrochemical profiles, short interventions, and comparator design. We propose a hydrochemical–phenotypic framework in which metabolic responses may depend on water composition, dose, exposure duration, and host phenotype. Current evidence does not support NMW as a treatment for T2DM but identifies specific metabolic pathways warranting rigorous clinical investigation.
- 18 August 2026
- Published by MDPI AG in Preprints.org
Open AccessNatural Mineral Water and Metabolic Regulation in Type 2 Diabetes: Current Evidence, Mechanistic Insights, and Future Directions
Natural mineral water (NMW) represents a heterogeneous hydrochemical exposure whose metabolic effects may depend on its complete mineral and physicochemical profile. This critical review evaluates human evidence on NMW consumption in relation to glucose regulation and metabolic pathways relevant to type 2 diabetes mellitus (T2DM), while distinguishing clinical findings from mechanistic plausibility. Controlled studies have not demonstrated a consistent glucose-lowering effect: oral glucose tolerance and postprandial glucose responses were generally unchanged, while longer-term reductions in fasting glucose were not clearly attributable to water composition. Conversely, selected studies identified potentially relevant intermediate responses, including altered postprandial insulin dynamics, reduced glycoalbumin, changes in oxidative status, gastrointestinal and microbiota-related variables, and favourable intestinal, inflammatory, and liver-related outcomes in metabolic dysfunction-associated steatotic liver disease. Human studies also establish mineral water as a bioavailable source of magnesium and calcium, although bioavailability does not imply metabolic efficacy. Interpretation remains limited by small samples, heterogeneous hydrochemical profiles, short interventions, and comparator design. We propose a hydrochemical–phenotypic framework in which metabolic responses may depend on water composition, dose, exposure duration, and host phenotype. Current evidence does not support NMW as a treatment for T2DM but identifies specific metabolic pathways warranting rigorous clinical investigation.
- Open Access
- 17 February 2024
- Published by MDPI AG in Medical Sciences
- Vol. 12 (1) , 11
Clinical Evidence on the Potential Beneficial Effects of Diet and Dietary Supplements against COVID-19 Infection Risk and Symptoms’ Severity
Background: Diet and dietary supplements aim to add trace elements, vitamins, and minerals to the body to improve human health and boost the immune system. In the previous few years, the new SARS-CoV-2 coronavirus strain has been threatening the health of individuals and public health more broadly, with rates of intensive care unit cases on the rise, while long-term COVID-19 complications are persisting until today. In the peculiar circumstances of the COVID-19 pandemic, in combination with disease prevention techniques, the strengthening of the immune system is considered particularly important to enable it to effectively respond to and eliminate the SARS-CoV-2 viral pathogen in the event of infection. The purpose of the current literature review is to thoroughly summarize and critically analyze the current clinical data concerning the potential beneficial effects of diet and dietary supplements against COVID-19 infection risk and symptoms’ severity. The micronutrients/supplements examined in this study in relation to COVID-19 infection are vitamins A, B, C, and D, zinc, selenium, magnesium, iron, omega-3 fatty acids, glutamine, resveratrol, beta-glucans, and probiotics. The potential effects of dietary patterns such as the Mediterranean diet against SARS-CoV-2 infection risk and symptoms’ severity were also analyzed. Our literature review suggests that micro- and macronutrient supplementation and a healthy diet and lifestyle may provide support to immune system function, with beneficial effects both before and during SARS-CoV-2 infection. However, additional studies are recommended to draw safe conclusions and formulate dietary recommendations concerning dietary supplements and their possible effects on preventing and co-treating COVID-19 disease.
- 17 February 2024
- Published by MDPI AG in Medical Sciences
- Vol. 12 (1) , 11
Open AccessClinical Evidence on the Potential Beneficial Effects of Diet and Dietary Supplements against COVID-19 Infection Risk and Symptoms’ Severity
Background: Diet and dietary supplements aim to add trace elements, vitamins, and minerals to the body to improve human health and boost the immune system. In the previous few years, the new SARS-CoV-2 coronavirus strain has been threatening the health of individuals and public health more broadly, with rates of intensive care unit cases on the rise, while long-term COVID-19 complications are persisting until today. In the peculiar circumstances of the COVID-19 pandemic, in combination with disease prevention techniques, the strengthening of the immune system is considered particularly important to enable it to effectively respond to and eliminate the SARS-CoV-2 viral pathogen in the event of infection. The purpose of the current literature review is to thoroughly summarize and critically analyze the current clinical data concerning the potential beneficial effects of diet and dietary supplements against COVID-19 infection risk and symptoms’ severity. The micronutrients/supplements examined in this study in relation to COVID-19 infection are vitamins A, B, C, and D, zinc, selenium, magnesium, iron, omega-3 fatty acids, glutamine, resveratrol, beta-glucans, and probiotics. The potential effects of dietary patterns such as the Mediterranean diet against SARS-CoV-2 infection risk and symptoms’ severity were also analyzed. Our literature review suggests that micro- and macronutrient supplementation and a healthy diet and lifestyle may provide support to immune system function, with beneficial effects both before and during SARS-CoV-2 infection. However, additional studies are recommended to draw safe conclusions and formulate dietary recommendations concerning dietary supplements and their possible effects on preventing and co-treating COVID-19 disease.
- Open Access
Diabesity and Dietary Interventions: Evaluating the Impact of Mediterranean Diet and Other Types of Diets on Obesity and Type 2 Diabetes Management
Background: Diabesity, the intersection of obesity and diabetes, presents a global health crisis with profound implications. Addressing diabesity requires multifaceted strategies, with diet playing a pivotal role. Over the last 15 years, clinical studies have intensified their exploration of various dietary approaches in diabesity management. This literature review aims to synthesize findings from clinical studies conducted in the last 15 years, shedding light on the efficacy, mechanisms, and nuances of different diet types in diabesity management with special focus on the Mediterranean diet (MD). Methods: Thorough research of academic databases yielded a collection of relevant clinical studies. These studies encompassed a range of dietary strategies, including the MD, low-carbohydrate diets, plant-based diets, high-protein diets, low-fat regimens, and intermittent fasting. Key findings, methodologies, and outcomes were thoroughly extracted and analyzed. Results: The last 15 years have witnessed considerable improvements in recognizing the role of human nutritional habits in diabesity management. The MD appears to be the most well-recognized diet, exerting favorable effects against both obesity and diabetes. Low-carbohydrate diets were found to enhance glycemic regulation and decrease insulin resistance. Plant-based diets demonstrated potential benefits in weight management and cardiometabolic health. High-protein, low-fat dietary models exhibited positive effects on satiety and body weight decline. Intermittent fasting regimens also exerted metabolic improvements and body weight decline. Personalization emerged as a crucial factor in dietary recommendations. Conclusions: Clinical studies from the last 15 years underscore the intricate relationship between diet types and diabesity management. The above results contribute to an increasing body of evidence, emphasizing the need for tailored dietary approaches and especially the MD. Healthcare providers can utilize this knowledge to offer personalized dietary recommendations for individuals with diabesity, potentially curbing the rise of these twin epidemics and improving the well-being of affected populations.
Open AccessDiabesity and Dietary Interventions: Evaluating the Impact of Mediterranean Diet and Other Types of Diets on Obesity and Type 2 Diabetes Management
Background: Diabesity, the intersection of obesity and diabetes, presents a global health crisis with profound implications. Addressing diabesity requires multifaceted strategies, with diet playing a pivotal role. Over the last 15 years, clinical studies have intensified their exploration of various dietary approaches in diabesity management. This literature review aims to synthesize findings from clinical studies conducted in the last 15 years, shedding light on the efficacy, mechanisms, and nuances of different diet types in diabesity management with special focus on the Mediterranean diet (MD). Methods: Thorough research of academic databases yielded a collection of relevant clinical studies. These studies encompassed a range of dietary strategies, including the MD, low-carbohydrate diets, plant-based diets, high-protein diets, low-fat regimens, and intermittent fasting. Key findings, methodologies, and outcomes were thoroughly extracted and analyzed. Results: The last 15 years have witnessed considerable improvements in recognizing the role of human nutritional habits in diabesity management. The MD appears to be the most well-recognized diet, exerting favorable effects against both obesity and diabetes. Low-carbohydrate diets were found to enhance glycemic regulation and decrease insulin resistance. Plant-based diets demonstrated potential benefits in weight management and cardiometabolic health. High-protein, low-fat dietary models exhibited positive effects on satiety and body weight decline. Intermittent fasting regimens also exerted metabolic improvements and body weight decline. Personalization emerged as a crucial factor in dietary recommendations. Conclusions: Clinical studies from the last 15 years underscore the intricate relationship between diet types and diabesity management. The above results contribute to an increasing body of evidence, emphasizing the need for tailored dietary approaches and especially the MD. Healthcare providers can utilize this knowledge to offer personalized dietary recommendations for individuals with diabesity, potentially curbing the rise of these twin epidemics and improving the well-being of affected populations.
- Open Access
- 6 February 2023
- Published by MDPI AG in Metabolites
- Vol. 13 (2) , 240
Clinical Evidence of Low-Carbohydrate Diets against Obesity and Diabetes Mellitus
The popularity of low-carbohydrate diets (LCDs) in the last few decades has motivated several research studies on their role in a variety of metabolic and non-morbid conditions. The available data of the results of these studies are put under the research perspective of the present literature review of clinical studies in search of the effects of LCDs on Obesity and Diabetes Mellitus. The electronic literature search was performed in the databases PubMed, Cochrane, and Embase. The literature search found seven studies that met the review’s inclusion and exclusion criteria out of a total of 2637 studies. The included studies involved randomized controlled trials of at least 12 weeks’ duration, in subjects with BMI ≥ 25 kg/m2, with dietary interventions. The results of the study on the effects of LCDs on obesity showed their effectiveness in reducing Body Mass Index and total body fat mass. In addition, LCDs appear to cause drops in blood pressure, low-density lipoprotein (LDL), and triglycerides, and seem to improve high-density lipoprotein (HDL) values. Regarding the effectiveness of LCDs in Diabetes Mellitus, their effect on reducing insulin resistance and fasting blood glucose and HbA1c values are supported. In conclusion, the results suggest the critical role of LCDs to improve the health of people affected by obesity or diabetes.
- 6 February 2023
- Published by MDPI AG in Metabolites
- Vol. 13 (2) , 240
Open AccessClinical Evidence of Low-Carbohydrate Diets against Obesity and Diabetes Mellitus
The popularity of low-carbohydrate diets (LCDs) in the last few decades has motivated several research studies on their role in a variety of metabolic and non-morbid conditions. The available data of the results of these studies are put under the research perspective of the present literature review of clinical studies in search of the effects of LCDs on Obesity and Diabetes Mellitus. The electronic literature search was performed in the databases PubMed, Cochrane, and Embase. The literature search found seven studies that met the review’s inclusion and exclusion criteria out of a total of 2637 studies. The included studies involved randomized controlled trials of at least 12 weeks’ duration, in subjects with BMI ≥ 25 kg/m2, with dietary interventions. The results of the study on the effects of LCDs on obesity showed their effectiveness in reducing Body Mass Index and total body fat mass. In addition, LCDs appear to cause drops in blood pressure, low-density lipoprotein (LDL), and triglycerides, and seem to improve high-density lipoprotein (HDL) values. Regarding the effectiveness of LCDs in Diabetes Mellitus, their effect on reducing insulin resistance and fasting blood glucose and HbA1c values are supported. In conclusion, the results suggest the critical role of LCDs to improve the health of people affected by obesity or diabetes.